Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acceleron Pharma
Biotech
Merck cardio plan forms as sotatercept, PCSK9 inhibitor impress
Merck is touting a duo of new data from its cardiovascular pipeline as proof that the company won't need a mega-merger to survive after Keytruda.
Max Bayer
Mar 6, 2023 12:00pm
Merck nails phase 3 sotatercept win a year after acquiring it
Oct 10, 2022 6:45am
Imara layoffs leave only 6 full-time employees standing
Apr 19, 2022 10:36am
Merck looks to cardiovascular pipeline for $10B-plus peak sales
Apr 5, 2022 5:24pm